Integral Derivatives’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Integral Derivatives’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-12,500	Closed	-$1.65M	–	1115
2017 Q4	$1.65M	Sell	12,500 -6,000	-32%	-$705K	0.03%	339
2017 Q3	$1.88M	Buy	+18,500	New	+$1.98M	0.03%	330
2016 Q3	–	Sell	-5,600	Closed	-$513K	–	1204
2016 Q2	$513K	Sell	5,600 -1,200	-18%	-$101K	0.01%	589
2016 Q1	$491K	Buy	+6,800	New	+$373K	0.02%	526

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Integral Derivatives's GWPH Position: Q1 2018 in Review

Integral Derivatives sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2018, closing a stake of 2,620 shares — an estimated $329K sold.

Integral Derivatives first reported a position in GWPH in Q2 2016 and held it in 3 quarters. The position peaked at $866K in Q3 2017. 191 funds tracked by Wall St. Rank hold GWPH as of Q1 2018.

Integral Derivatives reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2018 after selling out during the quarter.
Integral Derivatives sold 2,620 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2018, an estimated $329K.
Integral Derivatives first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2016 and held it in 3 quarters.
Integral Derivatives's GW Pharmaceuticals Plc American Depositary Shares position peaked at $866K in Q3 2017.
191 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.